Literature DB >> 22811537

Homeostasis and function of regulatory T cells in HIV/SIV infection.

Maria E Moreno-Fernandez1, Pietro Presicce, Claire A Chougnet.   

Abstract

Regulatory T cells (Tregs) play a pivotal role in the maintenance of tolerance as well as in the control of immune activation, particularly during chronic infections. In the setting of HIV infection, the majority of studies have reported an increase in Treg frequency but a decrease in absolute number in all immune compartments of HIV-infected individuals. Several nonexclusive mechanisms have been postulated to explain this preferential Treg accumulation, including peripheral survival, increased proliferation, increased peripheral conversion, and tissue redistribution. The role played by Tregs during HIV infection is still poorly understood, as two opposing hypotheses have been proposed. A detrimental role of Tregs during HIV infection was suggested based on the evidence that Tregs suppress virus-specific immune responses. Conversely, Tregs could be beneficial by limiting immune activation, thus controlling the availability of HIV targets as well as preventing immune-based pathologies. Despite the technical difficulties, getting a better understanding of the mechanisms regulating Treg dynamics remains important, as it will help determine whether we can successfully manipulate Treg function or number to the advantage of the infected host. The aim of this review is thus to discuss the recent findings on Treg homeostasis and function in the setting of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22811537      PMCID: PMC3457299          DOI: 10.1128/JVI.00993-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  97 in total

1.  Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.

Authors:  Jianuo Liu; Nan Gong; Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

2.  Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells.

Authors:  Rui Wang; Lina Kozhaya; Frances Mercer; Alka Khaitan; Hodaka Fujii; Derya Unutmaz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

3.  GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells.

Authors:  Dat Q Tran; John Andersson; Rui Wang; Heather Ramsey; Derya Unutmaz; Ethan M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

4.  HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.

Authors:  Jiaxiang Ji; Miles W Cloyd
Journal:  Int Immunol       Date:  2009-02-10       Impact factor: 4.823

5.  Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells.

Authors:  Christian Becker; Christian Taube; Tobias Bopp; Christoph Becker; Kai Michel; Jan Kubach; Sebastian Reuter; Nina Dehzad; Markus F Neurath; Kurt Reifenberg; Franz-Joseph Schneider; Edgar Schmitt; Helmut Jonuleit
Journal:  Blood       Date:  2009-05-13       Impact factor: 22.113

6.  CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.

Authors:  Andrew Lim; Martyn A French; Patricia Price
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

7.  Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets.

Authors:  Maria Nikolova; Jean-Daniel Lelievre; Matthieu Carriere; Armand Bensussan; Yves Lévy
Journal:  Blood       Date:  2009-02-25       Impact factor: 22.113

Review 8.  Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

9.  CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.

Authors:  Dorothy K Sojka; Angela Hughson; Deborah J Fowell
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

10.  Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells.

Authors:  Catherine M Card; Paul J McLaren; Charles Wachihi; Joshua Kimani; Francis A Plummer; Keith R Fowke
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

View more
  51 in total

1.  CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression.

Authors:  Patrick J Schuler; Bernard J C Macatangay; Zenichiro Saze; Edwin K Jackson; Sharon A Riddler; William G Buchanan; Benedict B Hilldorfer; John W Mellors; Theresa L Whiteside; Charles R Rinaldo
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

2.  Nonhuman Primate Testing of the Impact of Different Regulatory T Cell Depletion Strategies on Reactivation and Clearance of Latent Simian Immunodeficiency Virus.

Authors:  Ranjit Sivanandham; Adam J Kleinman; Paola Sette; Egidio Brocca-Cofano; Sindhuja Murali Kilapandal Venkatraman; Benjamin B Policicchio; Tianyu He; Cuiling Xu; Julia Swarthout; Zhirui Wang; Ivona Pandrea; Cristian Apetrei
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

3.  The effect of cellular isolation and cryopreservation on the expression of markers identifying subsets of regulatory T cells.

Authors:  Weiying Zhang; Tricia L Nilles; Jacquett R Johnson; Joseph B Margolick
Journal:  J Immunol Methods       Date:  2016-02-19       Impact factor: 2.303

4.  New tools to expand regulatory T cells from HIV-1-infected individuals.

Authors:  Mathieu Angin; Melanie King; Marylyn Martina Addo
Journal:  J Vis Exp       Date:  2013-05-30       Impact factor: 1.355

5.  CTLA-4+PD-1- Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques.

Authors:  Colleen S McGary; Claire Deleage; Justin Harper; Luca Micci; Susan P Ribeiro; Sara Paganini; Leticia Kuri-Cervantes; Clarisse Benne; Emily S Ryan; Robert Balderas; Sherrie Jean; Kirk Easley; Vincent Marconi; Guido Silvestri; Jacob D Estes; Rafick-Pierre Sekaly; Mirko Paiardini
Journal:  Immunity       Date:  2017-10-17       Impact factor: 31.745

6.  Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.

Authors:  Diego A Vargas-Inchaustegui; Peng Xiao; Alison E Hogg; Thorsten Demberg; Katherine McKinnon; David Venzon; Egidio Brocca-Cofano; Janet Dipasquale; Eun M Lee; Lauren Hudacik; Ranajit Pal; Yongjun Sui; Jay A Berzofsky; Linda Liu; Solomon Langermann; Marjorie Robert-Guroff
Journal:  Virology       Date:  2013-10-09       Impact factor: 3.616

7.  Profound loss of intestinal Tregs in acutely SIV-infected neonatal macaques.

Authors:  Xiaolei Wang; Huanbin Xu; Chanjuan Shen; Xavier Alvarez; David Liu; Bapi Pahar; Marion S Ratterree; Lara A Doyle-Meyers; Andrew A Lackner; Ronald S Veazey
Journal:  J Leukoc Biol       Date:  2014-12-09       Impact factor: 4.962

8.  Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Authors:  J Saison; T Ferry; J Demaret; D Maucort Boulch; F Venet; T Perpoint; F Ader; V Icard; C Chidiac; G Monneret
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

9.  Reciprocal relationship of T regulatory cells and monocytic myeloid-derived suppressor cells in LP-BM5 murine retrovirus-induced immunodeficiency.

Authors:  Megan A O'Connor; Jennifer L Vella; William R Green
Journal:  J Gen Virol       Date:  2015-08-06       Impact factor: 3.891

Review 10.  Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.

Authors:  S X Li; Ajs Armstrong; C P Neff; M Shaffer; C A Lozupone; B E Palmer
Journal:  Clin Pharmacol Ther       Date:  2016-04-16       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.